Dementia News and Research

Latest Dementia News and Research

Bayshore Home Health acquires Nightingale Nursing Group

Bayshore Home Health announced today the purchase of Saskatoon-based home health care company Nightingale Nursing Group Inc. The acquisition expands Bayshore's presence in the province, complements its existing office in Regina, and provides an opportunity to service additional remote northern communities.

27 Oct 2009

Barrett's esophagus patients are at no greater risk of dying than the rest of the population

New Mayo Clinic research has found that survival rates of patients with Barrett's esophagus, (http://www.mayoclinic.org/barretts-esophagus/) which can be a precursor for esophageal cancer, are no different than the survival rates for the general population. These findings were presented today at the 2009 American College of Gastroenterology (http://www.acg.gi.org/) (ACG) Annual Meeting in San Diego.

27 Oct 2009

Deep brain stimulation: New treatment option for people with severe Tourette syndrome

Deep brain stimulation may be a safe and effective treatment for Tourette syndrome, according to research published in the October 27, 2009, print issue of Neurology®, the medical journal of the American Academy of Neurology.

27 Oct 2009

Diabetes decreases cognitive decline in people with Alzheimer's disease

New research published in the October 27, 2009, print issue of Neurology®, the medical journal of the American Academy of Neurology, suggests that those with both diseases actually have a slower rate of memory loss than people who had only Alzheimer's disease.

27 Oct 2009

Los Angeles Jewish Home continues to meet nursing shortage in the country

While the healthcare industry bemoans a severe nursing shortage and sociologists warn of a growing health crisis amidst an aging population, the Los Angeles Jewish Home has continued to meet that challenge with its second graduating class from its innovative Annenberg School of Nursing.

24 Oct 2009

Nutri5, an effective natural product for the relief of menopausal symptoms

Earlier this year, the BBC reported that "HRT - Hormone Replacement Therapy - can shrink women's brains"1, after a study was published which showed that brain volume in women taking HRT was smaller in two key areas involved in thinking and memory.

23 Oct 2009

Alzheimer's Association appreciates RCN for its generous donation and awareness campaign

RCN Corporation recently donated more than $10,000 towards the Alzheimer's Association, National Capital Area Chapter's Reflections campaign and the nonprofit's signature event, the National Memory Walk. Earlier in the year, the company committed $210,000 in donated cable time for cross-channel spots about local Alzheimer initiatives in 2009.

23 Oct 2009

Alzheimer's Association Comfort Zone launched

Launched today, the Alzheimer's Association Comfort Zone(TM), powered by Omnilink, is the first comprehensive location management system designed specifically for Alzheimer's, giving people with the disease more freedom and independence in their community while providing their family some peace of mind.

22 Oct 2009

Blood test to identify MCI patients at risk of Alzheimer's disease

Elderly people exhibiting memory disturbances that do not affect their normal, daily life suffer from a condition called "mild cognitive impairment" (MCI). Some MCI patients go on to develop Alzheimer's disease within a few years, whereas other cases remain stable, exhibiting only benign senile forgetfulness. It is crucial to develop simple, blood-based tests enabling early identification of these patients that will progress in order to begin therapy as soon as possible, potentially delaying the onset of dementia.

22 Oct 2009

Eyes may mirror Alzheimer's disease

The eyes may be the windows to the soul, but new research indicates they also may mirror a brain ravaged by Alzheimer's disease.

22 Oct 2009

Contribution of glycosaminoglycans to skeletal abnormalities in patients with lysosomal storage diseases demonstrated

A group led by Dr. Dieter Br-mme at the University of British Columbia has demonstrated that glycosaminoglycans (GAGs) contribute to skeletal abnormalities in patients with lysosomal storage diseases. Their report can be found in the November 2009 issue of The American Journal of Pathology.

21 Oct 2009

MMPF technique for diagnosing and predicting brain syndromes

NASA technology will now be available to the medical community to help in the diagnosis and prediction of syndromes that affect the brain, such as stroke, dementia, and traumatic brain injury.

21 Oct 2009

Researchers use biotechnological tools to find a cure for Alzheimer's disease

No one has yet found a cure or a way to prevent people from developing Alzheimer's disease. Researchers from the Swedish University of Agricultural Sciences, among others, are breaking new ground in biotechnology to find new tools that can help provide new solutions.

20 Oct 2009

Antioxidant extracts of G.biloba leaves may protect cells from radiation damage

Antioxidant extracts of the leaves of the Gingko biloba tree may protect cells from radiation damage, according to a study published in the International Journal of Low Radiation. The discovery may one day be used to help reduce side effects in cancer patients undergoing radiotherapy.

20 Oct 2009

Studies find frail seniors often get poor, futile care

Two studies published in the New England Journal of Medicine find that some medical care, especially at the end of life, may be a poor choice for feeble seniors. They also show the importance of palliative care over aggressive treatment for certain patients.

19 Oct 2009

Novel HIV drug to be studied in cell cultures and patients

A $6 million, five-year federal grant to The Children's Hospital of Philadelphia Research Institute will enable researchers to investigate a novel approach in treating HIV infection---a unique class of drugs focused on developing therapies for psychological and neurological effects in AIDS.

19 Oct 2009

ADDF grant to support the evaluation of PPAR-sparing insulin sensitizers

Metabolic Solutions Development Company (MSDC) announced today that it has received a $100,000 grant from the Alzheimer's Drug Discovery Foundation (ADDF) to support the evaluation of PPAR-sparing insulin sensitizers as a potential treatment for Alzheimer's disease.

14 Oct 2009

Vanda Pharmaceuticals announces its agreement with Novartis Pharma AG

Vanda Pharmaceuticals Inc. announced today that it has entered into an agreement with Novartis Pharma AG to commercialize and develop Fanapt(TM) (iloperidone), Vanda's anti-psychotic, in the U.S. and Canada. Fanapt(TM) was approved by the U.S. Food and Drug Administration on May 6, 2009 for the acute treatment of schizophrenia in adults.

14 Oct 2009

AVANIR Pharmaceuticals announces results of Zenvia double-blind Phase III STAR trial

AVANIR Pharmaceuticals, Inc. today announced detailed results from the confirmatory double-blind Phase III STAR trial evaluating two doses of the investigational drug Zenvia™ (dextromethorphan/quinidine) compared to placebo in the treatment of pseudobulbar affect (PBA) in patients with underlying multiple sclerosis (MS) or amyotrophic lateral sclerosis (ALS).

14 Oct 2009

New mouse models resembles human ALS; may provide important tool for screening new drugs

A new mouse model of amyotrophic lateral sclerosis (ALS) closely resembles humans with the paralyzing disorder, researchers at Washington University School of Medicine in St. Louis report.

13 Oct 2009